Topical cidofovir for benign human papillomavirus–associated skin lesions
L Napolitano, L Schroedl, A Kerman… - Antiviral …, 2021 - journals.sagepub.com
Cidofovir is a broad-spectrum antiviral agent that has shown efficacy against skin lesions
caused by human papillomavirus (HPV). We present a case of extensive verruca vulgaris …
caused by human papillomavirus (HPV). We present a case of extensive verruca vulgaris …
Topical cidofovir for benign human papillomavirus-associated skin lesions
L Napolitano, L Schroedl, A Kerman… - Antiviral …, 2021 - pubmed.ncbi.nlm.nih.gov
Cidofovir is a broad-spectrum antiviral agent that has shown efficacy against skin lesions
caused by human papillomavirus (HPV). We present a case of extensive verruca vulgaris …
caused by human papillomavirus (HPV). We present a case of extensive verruca vulgaris …
Topical cidofovir for benign human papillomavirus–associated skin lesions.
L Napolitano, L Schroedl, A Kerman… - Antiviral …, 2021 - search.ebscohost.com
Cidofovir is a broad-spectrum antiviral agent that has shown efficacy against skin lesions
caused by human papillomavirus (HPV). We present a case of extensive verruca vulgaris …
caused by human papillomavirus (HPV). We present a case of extensive verruca vulgaris …
Topical cidofovir for benign human papillomavirus-associated skin lesions.
L Napolitano, L Schroedl, A Kerman, CR Shea - Antiviral Therapy, 2021 - europepmc.org
Cidofovir is a broad-spectrum antiviral agent that has shown efficacy against skin lesions
caused by human papillomavirus (HPV). We present a case of extensive verruca vulgaris …
caused by human papillomavirus (HPV). We present a case of extensive verruca vulgaris …